Nav: Home

Bacterial membrane vesicles can cause preterm birth

September 01, 2016

Approximately 20-30% of women carry bacteria called group B streptococcus (GBS) in their vagina or rectum. In most cases, these bacteria cause no problems, but GBS has been linked to complications during pregnancy, including pre-term delivery.

A study published on September 1st in PLOS Pathogens reports that GBS produces membrane-bound vesicles containing bacterial factors that can attack the host tissue. In mice, the study shows, these vesicles can move from the vagina to the uterus and cause inflammation of the membranes surrounding the fetus. When injected directly into the amniotic cavity of mice, these vesicles can induce preterm and still births.

Membrane-bound vesicles (MVs) loaded with toxins, immune-modulators, and other bacterial factors, contribute to the survival and virulence (the ability to cause disease) of many pathogenic bacteria. Whether GBS produces MVs was not known. However, because in pregnant women who carry GBS and deliver prematurely, bacterial infection is rarely found in the womb, Anirban Banarjee, from the Indian Institute of Technology Bombay, and colleagues hypothesized that if GBS produces MVs, they might move up to the womb during pregnancy and cause tissue damage at interface between mother and fetus.

To test this, the researchers started by growing GBS in liquid media. When they removed the bacteria and examined the remaining liquid by electron microscopy, they found numerous spherical structures. Zooming in on the surface of growing bacteria, they detected vesicles that were just budding off the bacterial cell, confirming that GBS produces MVs. They next examined the protein content of the MVs and identified 8 bacterial proteins, all with predicted properties of virulence factors that can attack the human host and cause disease.

When the researchers mixed MVs and cells of human origin, they found that the MVs can invade and kill these cells, suggesting that GBS MVs are toxic to the human host. The researchers then deposited the MVs without the bacteria into mouse vagina and hours later found them throughout the uterus and in the developing fetus, indicating that MVs can indeed travel up the birth canal. Adding MVs to mouse chorio-decidual membrane (which is found at the interface between mother and fetus) caused collagen degradation, reducing the elasticity and weakening the mechanical properties of the membrane.

When the researchers injected MVs directly into the amniotic sac (the fluid-filled cavity surrounding the embryo) of pregnant mice, they observed that 24 hours later the tissue of the interface between mother and fetus was severely disrupted, with broken collagen fibers, hallmarks of inflammation, and signs of extensive cell death. To test whether these changes could lead to pre-term birth, the researchers carefully monitored females whose amniotic sacs had been injected with MVs at day 14.5 of pregnancy (a full-term mouse pregnancy lasts 19 days). Approximately 60% of the fetuses were born prematurely (by day 18 of pregnancy), compared with only 10% of pups following control injection with saline. Along with preterm birth, the researchers observed an increased frequency of fetal death in utero, and that the pups born to MV injected mothers were too small and some had abnormal morphology. Collectively, these results suggest that GBS MVs can cause preterm birth and fetal injury.

Discussing their results, the researchers emphasize the finding that MVs alone could induce features resembling clinical chorio-amnionitis in the mice. "Clinically", they say, "this observation is highly relevant as 50-80% women with chorio-amnionitis do not have bacteria in their amniotic fluid or the decidual tissue". Based on their study, they hypothesize that "MVs secreted by the pathogens residing in lower genital tract may be responsible for cases with unexplained chorio-amnionitis".

Acknowledging the gap between experimental results in mice following direct injection of MVs into the amnion sac and human pathogenesis, the researchers nevertheless suggest that their findings "provide a novel insight into how GBS while simply sitting in the vagina can orchestrate events at the fetal membrane leading to premature birth". Because MVS are not susceptible to antibiotics, the researchers speculate that instead "new drugs that prevent vesicle production may [...] be a viable therapeutic option to prevent GBS mediated preterm birth".
-end-
In your coverage please use this URL to provide access to the freely available article in PLOS Pathogens: http://dx.plos.org/10.1371/journal.ppat.1005816

Please contact plospathogens@plos.org if you would like more information.

Funding: MVS and SB acknowledge University Grants Commission (UGC, Govt. of India), AA acknowledges Council of Scientific and Industrial Research (CSIR, Govt. of India) and KGK acknowledges Department of Science and Technology (DST, Govt. of India) for fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Competing Interests: The authors have declared that no competing interests exist.

Citation: Surve MV, Anil A, Kamath KG, Bhutda S, Sthanam LK, Pradhan A, et al. (2016) Membrane Vesicles of Group B Streptococcus Disrupt Feto-Maternal Barrier Leading to Preterm Birth. PLoS Pathog 12(9): e1005816. doi:10.1371/journal.ppat.1005816

PLOS

Related Bacteria Articles:

How bees live with bacteria
More than 90 percent of all bee species are not organized in colonies, but fight their way through life alone.
The bacteria building your baby
Australian researchers have laid to rest a longstanding controversy: is the womb sterile?
Detecting bacteria in space
A new genomic approach provides a glimpse into the diverse bacterial ecosystem on the International Space Station.
Hopping bacteria
Scientists have long known that key models of bacterial movement in real-world conditions are flawed.
Bacteria uses viral weapon against other bacteria
Bacterial cells use both a virus -- traditionally thought to be an enemy -- and a prehistoric viral protein to kill other bacteria that competes with it for food according to an international team of researchers who believe this has potential implications for future infectious disease treatment.
More Bacteria News and Bacteria Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Rethinking Anger
Anger is universal and complex: it can be quiet, festering, justified, vengeful, and destructive. This hour, TED speakers explore the many sides of anger, why we need it, and who's allowed to feel it. Guests include psychologists Ryan Martin and Russell Kolts, writer Soraya Chemaly, former talk radio host Lisa Fritsch, and business professor Dan Moshavi.
Now Playing: Science for the People

#537 Science Journalism, Hold the Hype
Everyone's seen a piece of science getting over-exaggerated in the media. Most people would be quick to blame journalists and big media for getting in wrong. In many cases, you'd be right. But there's other sources of hype in science journalism. and one of them can be found in the humble, and little-known press release. We're talking with Chris Chambers about doing science about science journalism, and where the hype creeps in. Related links: The association between exaggeration in health related science news and academic press releases: retrospective observational study Claims of causality in health news: a randomised trial This...